ARTICLE | Company News
Myriad Genetics, Laboratory Corp. of America Holdings sales and marketing update
December 10, 2001 8:00 AM UTC
MYGN granted LH exclusive sales and distribution rights to MYGN's predictive medicine products. For an upfront fee, LH will receive the right to market to primary care physicians MYGN's BRACAnalysis,...